Evidence map›Paper›PMID 30554356›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2019

Italian recommendations for diagnosis and management of congenital myasthenic syndromes.

Lorenzo Maggi, Pia Bernasconi, Adele D'Amico, Raffaella Brugnoni, Chiara Fiorillo, Matteo Garibaldi, Guja Astrea, Claudio Bruno, Filippo Maria Santorelli, Rocco Liguori and 5 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06630650 (A Single Center Prospective Natural History and Outcome Measure Validation Study of Congenital Myasthenic Syndromes), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06630650 recruitingnot on this mapstarted 2025, after this paper: background citation

A Single Center Prospective Natural History and Outcome Measure Validation Study of Congenital Myasthenic Syndromes

TypeobservationalSponsorNational Institute of Neurological Disorders and Stroke (NINDS)Ran2025 to 2044Enrolled75ConditionsMyasthenic Syndromes, Congenital
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Favorable outcome of COVID-19 infection in a patient with congenital myasthenic syndrome.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Article
  7. Salbutamol as effective treatment in slow-channel syndrome- first report.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Article
  8. Article
  9. Article
  10. Review
  11. Practical approach to respiratory emergencies in neurological diseases.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Review
  12. Rare Neurologic Diseases and Neurological Sciences: a report for the celebration of the 2020 Rare Diseases Day.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Article
  13. Italian recommendations for the diagnosis and treatment of myasthenia gravis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2019
    Article
  14. Rare Diseases Day and Brain Awareness Week: the active participation of Neurological Sciences.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Lorenzo MaggiNeurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico "Carlo Besta", Via Celoria 11, 20133, Milan, Italy. lorenzo.maggi@istituto-besta.it.ORCID http://orcid.org/0000-0002-0932-5173
Pia BernasconiNeurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico "Carlo Besta", Via Celoria 11, 20133, Milan, Italy.
Adele D'AmicoUnit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Research Hospital, IRCCS, Rome, Italy.
Raffaella BrugnoniNeurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico "Carlo Besta", Via Celoria 11, 20133, Milan, Italy.
Chiara FiorilloPaediatric Neurology and Neuromuscular Disorders Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Istituto Giannina Gaslini, Genoa, Italy.
Matteo GaribaldiUnit of Neuromuscular Disorders, Department of Neurology, Mental Health and Sensory Organs (NESMOS), Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Guja AstreaMolecular Medicine, IRCCS Fondazione Stella Maris, Pisa, Italy.
Claudio BrunoTranslational and Experimental Myology Centre, Istituto Giannina Gaslini, Genoa, Italy.
Filippo Maria SantorelliMolecular Medicine, IRCCS Fondazione Stella Maris, Pisa, Italy.
Rocco LiguoriDepartment of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Giovanni AntoniniUnit of Neuromuscular Disorders, Department of Neurology, Mental Health and Sensory Organs (NESMOS), Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Amelia EvoliNeurology Institute, Università Cattolica del Sacro Cuore, Rome, Italy.
Enrico BertiniUnit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Research Hospital, IRCCS, Rome, Italy.
Carmelo RodolicoDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Renato MantegazzaNeurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico "Carlo Besta", Via Celoria 11, 20133, Milan, Italy.
Fondazione IRCCS Istituto Neurologico Carlo Besta · ITAzienda Ospedaliera Sant'Andrea · ITBambino Gesù Children's Hospital · ITFondazione Stella Maris · ITIstituto Giannina Gaslini · ITIstituto delle Scienze Neurologiche di Bologna · ITUniversità Cattolica del Sacro Cuore · ITUniversity of Messina · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital myasthenic syndromes (CMS) are genetic disorders due to mutations in genes encoding proteins involved in the neuromuscular junction structure and function. CMS usually present in young children, but perinatal and adult onset has been reported. Clinical presentation is highly heterogeneous, ranging from mild symptoms to severe manifestations, sometimes with life-threatening respiratory episodes, especially in the first decade of life. Although considered rare, CMS are probably underestimated due to diagnostic difficulties. Because of the several therapeutic opportunities, CMS should be always considered in the differential diagnosis of neuromuscular disorders. The Italian Network on CMS proposes here recommendations for proper CMS diagnosis and management, aiming to guide clinicians in their practical approach to CMS patients.

Indexed as

Disease ManagementHealth Planning GuidelinesMyasthenic Syndromes, CongenitalHumansItalyCongenital myasthenic syndromesMyasthenia gravisMyopathyNeuromuscular junctionRecommendations

Identifiers

PMID30554356
OpenAlexW2905013103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.